Company Profiles

driven by the PitchBook Platform

Truveris

Truveris
2009 FOUNDED
PRIVATE STATUS
51-200 EMPLOYEES
Series D LATEST DEAL TYPE
$24.7M LATEST DEAL AMOUNT
$53.7M TOTAL AMOUNT RAISED
Description

Operator of a health information technology platform designed to offer prescription benefit plans and payers of claims. The company's health information technology platform helps payers of pharmacy benefits validate claim payment accuracy, ensure regulatory compliance and manage pharmacy spend with their scalable, automated, easy to implement claims analysis engine, enabling clients to effectively and efficiently manage the complexity and rising costs of prescription drugs .

Website:
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Application Software
Other Industries
Database Software
Other Software
Primary Office
2 Park Avenue
Suite 1500
New York, NY 10016
United States

+1 (800) 430-1430
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Truveris’s full profile, request a free trial.

Truveris Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series D) 29-Aug-2017 $24.7M $53.7M 00000 Completed Generating Revenue
4. Later Stage VC (Series C) 24-Mar-2016 00.00 0000 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 26-Jun-2014 000.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 23-Feb-2012 $10M $13.8M $34.7M Completed Generating Revenue
1. Early Stage VC (Series A) 02-Feb-2011 $3.79M $3.79M $10.9M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding request access »

Truveris Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series D 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 16,170,240 $0.001000 6% $0.62 $0.62 1x $0.62 14.94%
Series A 13,853,857 $0.001000 6% $0.27 $0.27 1x $0.27 12.8%
To view this company’s complete Cap Table request access »

Truveris Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Brian Hirsch Angel (individual) Minority 000 0000 000000 0
Canaan Partners Venture Capital Minority 000 0000 000000 0
First Round Capital Venture Capital Minority 000 0000 000000 0
McKesson Ventures Corporate Venture Capital Minority 000 0000 000000 0
NAV.VC Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Truveris Executive Team (9)

Name Title Board
Seat
Contact
Info
Faisal Mushtaq Chief Executive Officer, Board Member & President
Michael Facendola Chief Financial Officer & Secretary
Bertrand Janin Chief Technology Officer
Jeff Ignaszak Chief Marketing Officer
Tim Herlehy Chief Revenue Officer
You’re viewing 5 of 9 executives. Get the full list »

Truveris Board Members (12)

Name Representing Role Since Contact
Info
A. Loiacono Self Board Member, Co-Founder & Chief Innovation Officer 000 0000
Brian Hirsch Tribeca Venture Partners Board Member 000 0000
Matthew Simas Truveris Board Member 000 0000
Scott Johnson NAV.VC Board Observer 000 0000
Stephen Bloch MD Canaan Partners Board Member 000 0000

6 Former Board Members

You’re viewing 5 of 12 board members. Get the full list »